Chatbots are far more predictable in their responses than you might expect. That's fine for research or coding, but it's a ...

Artificial intelligence has moved quickly from experimentation to real use inside the finance function. Controllers, chief accounting officers and CFOs are being asked to evaluate how AI can support ...

Save big with discount apps: Prescription discount apps like GoodRx, Cost Plus Drugs, and SingleCare can often beat your insurance price, saving consumers hundreds of dollars. Shop around before every ...

Reliable access to medicines has always mattered, but in today’s healthcare environment it has become a defining issue for pharmacy operations and patient care. Drug shortages, supply disruptions, and ...

The US Supreme Court ruled yesterday, June 4, that pharmaceutical company Hikma’s generic cardiovascular drug does not infringe global biopharmaceutical company Amarin’s patents covering its drug ...

A unanimous Supreme Court reversed the Federal Circuit and held that Amarin did not plausibly allege that Hikma’s skinny label and marketing actively induced infringement of Vascepa’s ...

In recent weeks, Canada became the first G7 country to approve a generic version of the popular drug Ozempic. Elizabeth Doran has been taking GLP-1 medications for nearly a year for weight loss to ...

The U.S. allows drugmakers to extend their patent terms to prevent cheaper generic drugs from entering the market sooner. That's bad for patients. Several countries will soon get generic versions of ...

Hims & Hers Health (HIMS) on Thursday announced the launch of generic versions of Novo Nordisk’s (NVO) blockbuster GLP-1 therapy semaglutide through its telehealth platform in Canada. The ...